CY

Chetan Yashwant Rane

Active Director Director DIN 09588178
DIN 09588178 First appointment Apr 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Chetan Yashwant Rane

Data last updated:

Chetan Yashwant Rane is a Director at Nexicon Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Nexicon Pharmaceuticals Private Limited reported revenue of ₹6.83 Cr (FY 2024).

DIN 09588178
Primary Designation Director
Industry Pharma
First Appointment 27 Apr 2022
Oldest Company Age 4 yrs
Largest company Nexicon Pharmaceuticals Private Limited · ₹6.83 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Apr 20222022₹6.83 Cr (FY 2024)Active

Board colleagues of Chetan Yashwant Rane

NameDINCompanyDesignation
Yogesh Dinesh Nemade09376203Nexicon Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nexicon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Chetan Yashwant Rane

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chetan Yashwant Rane

Chetan Yashwant Rane currently holds 1 directorship: Nexicon Pharmaceuticals Private Limited (Director, since 27 Apr 2022, revenue ₹6.83 Cr (FY 2024)).

Chetan Yashwant Rane was first appointed on 27 Apr 2022 as Director at Nexicon Pharmaceuticals Private Limited.

The current boards of Chetan Yashwant Rane's companies include Yogesh Dinesh Nemade (Nexicon Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available